Geneos Wealth Management’s Core Alternative Capital CCOR Stock Holding History
Bought
Maintained
Sold
Other funds holding CCOR
IFAM
AWA
APCM
PFA
SB
HH
Geneos Wealth Management's CCOR Position: Q1 2024 in Review
Geneos Wealth Management sold out of Core Alternative Capital (CCOR) in Q1 2024, closing a stake of 397 shares — an estimated $10.9K sold.
Geneos Wealth Management first reported a position in CCOR in Q4 2022 and held it in 5 quarters. The position peaked at $13.8K in Q1 2023. 40 funds tracked by Wall St. Rank hold CCOR as of Q1 2024.
- Geneos Wealth Management reported no remaining Core Alternative Capital position as of Q1 2024 after selling out during the quarter.
- Geneos Wealth Management sold 397 Core Alternative Capital shares in Q1 2024, an estimated $10.9K.
- Geneos Wealth Management first reported a position in Core Alternative Capital in Q4 2022 and held it in 5 quarters.
- Geneos Wealth Management's Core Alternative Capital position peaked at $13.8K in Q1 2023.
- 40 funds tracked by Wall St. Rank held Core Alternative Capital as of Q1 2024.
Based on Geneos Wealth Management's 13F filing for Q1 2024, filed 3 May 2024.